Profile of Depressive Symptoms in Parkinsons Disease

CompletedOBSERVATIONAL
Enrollment

1,018

Participants

Timeline

Start Date

April 1, 2006

Primary Completion Date

October 1, 2006

Study Completion Date

October 1, 2006

Conditions
Parkinson DiseaseDepression
Interventions
DRUG

Pramipexole

Trial Locations (24)

1090

Boehringer Ingelheim Investigational Site, Vienna

1130

Boehringer Ingelheim Investigational Site, Vienna

1211

Hopital Cantonal (HUG), Geneva

6020

Boehringer Ingelheim Investigational Site, Innsbruck

6614

Clinica Hildebrand, Brissago

9007

Kantonsspital St. Gallen, Sankt Gallen

11519

Hospital Puerta del Mar. Neurology, Cadiz

14547

Neurologisches Fachkrankenhaus fur, Beelitz-Heilstätten

16100

Azienda Ospedaliera S. Martino, Genova

31059

Hopital Rangueil, Toulouse

31073

Hopital Purpan, Toulouse

35638

Gertrudis-Kliniken Biskirchen, Leun

48903

Hospital de Cruces. Neurology, Baracaldo / Bilbao

77709

Parkinson Klinik Wolfach, Wolfach

80131

Universita Federico II, Napoli

82008

Boehringer Ingelheim Investigational Site, Unterhaching

95125

Policlinico di Catania, Catania

01307

Universitatsklinikum Carl Gustav Carus Dresden, Dresden

07551

Boehringer Ingelheim Investigational Site, Gera

00161

Universita La Sapienza di Roma, Roma

6229 HX

Academisch Ziekenhuis Maastricht, Maastricht

08036

Hospital Clinic i Provincial. Neurology, Barcelona

NW3 2QG

Boehringer Ingelheim Investigational Site, London

NG24 4DE

Boehringer Ingelheim Investigational Site, Newark

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00349310 - Profile of Depressive Symptoms in Parkinsons Disease | Biotech Hunter | Biotech Hunter